< Major Announcements After Market Close >


◆ Alteogen = Signed clinical and sales license agreement for ALT-L9 with Altos Biologics


◆ Baekgeum T&A = Exchange requests disclosure regarding significant market fluctuations



◆ Yujin Enterprise = Termination of supply contract worth 110.7 billion KRW


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing